Keila DePape
Digital Reporter at CFCF-TV (Montreal, QC)
Former journalist from the prairies writing about breakthroughs in health research at McGill University.
Articles
-
1 week ago |
medicalxpress.com | Keila DePape
A McGill University-led research collaboration has achieved a breakthrough in understanding how cancer spreads. A clinical study of ovarian and colorectal cancer patients found cancer cells move in the bloodstream in clusters more commonly than was previously thought. The discovery could help doctors more quickly identify which cancer patients are at high risk of having their cancer spread to other organs, knowledge that could guide treatment decisions.
-
3 weeks ago |
medicalxpress.com | Keila DePape
In a preclinical study led by McGill University researchers, two drugs targeting "zombie cells" have been shown to treat the underlying cause of chronic low back pain. The condition affects millions of people worldwide. Current treatments manage symptoms through painkillers or surgery, without addressing the root cause.
-
1 month ago |
phys.org | Keila DePape
McGill University researchers have developed an AI-powered method to verify the origin of honey, ensuring that what's on the label matches what's in the jar. The breakthrough, published in Analytical Chemistry, offers a potential solution to a long-standing problem. "Honey is one of the most fraud-prone commodities in global trade.
-
1 month ago |
medicalxpress.com | Keila DePape
A McGill University-led study has found that people with cannabis use disorder (CUD) had elevated dopamine levels in a brain region associated with psychosis. The findings are published in the journal JAMA Psychiatry. "This could help explain why cannabis use increases the risk of hallucinations and delusions, key symptoms of schizophrenia and other psychotic disorders," said first author Jessica Ahrens, a Ph.D. student in McGill's Integrated Program in Neuroscience.
-
1 month ago |
medicalxpress.com | Keila DePape
New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say. The researchers looked at how often people with immune-mediated inflammatory diseases (IMIDs) got COVID-19 despite having received at least three doses of an mRNA COVID-19 vaccine.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 398
- Tweets
- 200
- DMs Open
- No
RT @McGilluMedia: .@mcgillu researchers develop AI model to detect the spread of metastatic brain cancer using MRI scans 🧠➡️https://t.co/mZ…
RT @McGilluMedia: New study links alcohol consumption to more severe nut allergy reaction 🥜🍷➡️ https://t.co/sIfdVeIBTa @RIMUHC1 @McGillMed…
RT @McGilluMedia: New drug shows promise against Duchenne muscular dystrophy, finds new @mcgillu research published in @LSAjournal https://…